细胞命运的获取和重编程由前神经转录因子ASCL1进行
Jethro Lundie-Brown1, Francesca Puletti2, Anna Philpott1,3
1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Open biology
|June 17, 2025
概括
转录因子ASCL1 (急性类似的bHLH转录因子1) 对神经系统发育和神经元重编程至关重要. 这篇评论详细介绍了它在细胞身份,发育和癌症中的作用,强调了治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 癌症生物学 癌症生物学
背景情况:
- ASCL1 (急性类似的bHLH转录因子1) 是一个关键的proneural基本螺旋环螺旋 (bHLH) 转录因子.
- 它在神经系统的发育,维护和体细胞对神经元命运的重编程中起着至关重要的作用.
- 在ASCL1未能诱导神经发生或重编程的情况下,存在例外情况,并且它与神经母细胞瘤和质母细胞瘤等癌症有关.
研究的目的:
- 为ASCL1的各种功能提供全面的概述.
- 将基础知识与最近在ASCL1的后翻译和转录监管方面的进展相结合.
- 提供关于ASCL1的分子机制和在发育,重编程和癌症中的治疗潜力的见解.
主要方法:
- 对ASCL1在神经元分化中的作用进行基础研究的综述.
- 纳入最近关于ASCL1的翻译后修改的研究.
- 对ASCL1的转录控制机制的最新发现进行分析.
主要成果:
- ASCL1通过重新配置染色质,是神经元身份的强有力的驱动器.
- 它的功能取决于上下文,有些细胞类型难以重编程.
- 在某些发育背景下,ASCL1会影响非神经元系.
- ASCL1是神经母细胞瘤和质母细胞瘤发病的一个重要因素.
结论:
- 对ASCL1的多方面的作用有充分的了解对于临床应用至关重要.
- 在翻译后和转录水平上,ASCL1的调节决定了其多样化的细胞结果.
- 对ASCL1分子功能的进一步了解可以为发育障碍和癌症解锁治疗策略.
相关概念视频
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Determination
19.3K
During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
19.3K
Lineage Commitment
3.2K
Commitment is the process whereby stem cells:
3.2K
Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K


